• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIO:GR

71.490 EUR 1.424 2.03%

As of 06:52:10 ET on 10/21/2014.

Snapshot for Biotest AG (BIO)

Open: 70.210 Day's Range: 69.498 - 71.490 Volume: 424
Previous Close: 70.066 52wk Range: 59.260 - 94.700 1-Yr Rtn: +18.47%

Stock Chart for BIO

No chart data available.
  • BIO:GR 71.490
  • 1D
  • 1M
  • 1Y
70.066
Interactive BIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIO

Current P/E Ratio (ttm) 30.4402
Estimated P/E(12/2014) -
Relative P/E vs. DAX 1.8848
Earnings Per Share (EUR) (ttm) 2.3400
Est. EPS (EUR) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 947.63
Shares Outstanding (M) 6.60
30 Day Average Volume 2,121
Price/Book (mrq) 2.0064
Price/Sale (ttm) 1.7797
Dividend Indicated Gross Yield 0.80%
Cash Dividend (EUR) 0.5700
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth 13.70%
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIO

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BIO

Biotest AG develops, produces and markets pharmaceuticals, as well as diagnostic and testing products and equipment for human and veterinarian applications. The Company provides a wide range of immune, molecular-biological and antibody test systems, as well as medical test devices. Biotest manages research and production operations mainly in Europe and sells its products worldwide.

Gregor SchulzChairman-Mgmt BoardMichael RamrothCFO/Member-Mgmt Board
Georg FlossMember-Mgmt Board
More Company Profile & Key Executives for BIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil